Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Medicamen Biotech Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

20/100
265.50
-2.80 (-1.04%)

As on 21 Apr, 2026 | 11:24

Open Trading A/c
Day Range
262.53
273.00
L H
52 Week Range
216.95
482.40
L H
Volume
8,545
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
7 264.90 265.90 37
53 264.85 265.95 97
50 264.75 266.15 46
15 264.65 266.60 50
37 264.45 266.65 50
7622 Total Total 828
Bid / Ask
264.90 / 265.90
20/100
266.05
-1.15 (-0.43%)

As on 21 Apr, 2026 | 11:25

Open Trading A/c
Day Range
262.50
269.15
L H
52 Week Range
220.00
481.50
L H
Volume
394
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
7 264.90 265.90 37
53 264.85 265.95 97
50 264.75 266.15 46
15 264.65 266.60 50
37 264.45 266.65 50
7622 Total Total 828
Bid / Ask
264.90 / 265.90
NSE
MC Essentials
35% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Low Growth Trend Stock Priced at Expensive Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 266.96
          Previous Close 268.30
          Volume 8,545.00
          Value (Lacs) 22.69
            VWAP 265.77
          Beta
          Mkt Cap (Rs. Cr.) 360
          High 273.00
          Low 262.53
          UC Limit 321.96
          LC Limit 214.64
          52 Week High 482.40
          52 Week Low 216.95
          Face Value 10.00
          All Time High 1,225.00
          All Time Low 216.95
          20D Avg Volume 50,214
          20D Avg Delivery(%) 59.10
          Book Value Per Share 204.24
          Dividend Yield 0.38
          TTM EPS See historical trend 6.95 (+12.48% YoY)
          TTM PE See historical trend 38.20 (Low PE)
          P/B See historical trend 1.30 (Low P/B)
          Sector PE 39.83

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          20/100
          Average Financial Strength, Low Growth Trend Stock Priced at Expensive Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 44.96% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 40.46% in Mar 2026 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          4 out of 5 years Medicamen Biotech has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 50.98% (2024) 20.76% -11.07% (2025) -11.07% 14.39%

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling

          What's your call on  today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          24 Sep, 2025

          sanjay bansal

          Qty 100,000 Price 0.00 % Traded 0.00
          22 Mar, 2025

          shivalik rasayan limited

          Qty 21,000 Price 494.14 % Traded 0.00
          17 Dec, 2024

          geetika madan

          Qty 3,000 Price 448.65 % Traded 0.02
          17 Dec, 2024

          geetika madan

          Qty 2,000 Price 572.29 % Traded 0.01
          17 Dec, 2024

          geetika madan

          Qty 313 Price 612.17 % Traded 0.00
          18 Sep, 2024

          geetika madan

          Qty 1,490 Price 475.86 % Traded 0.01
          18 Sep, 2024

          geetika madan

          Qty 1,000 Price 398.20 % Traded 0.01
          26 Mar, 2024

          geetika madan

          Qty 2,449 Price 428.07 % Traded 0.02

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Medicamen Biotech Limited is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. It is a manufacturer and supplier of a range of products, such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum), and ointment. Its product offerings include Acarbrose Tablets 50 milligram, Acetazolamide Tablet 250 milligram BP, Amitriptyline Hcl Tablet 25 milligram, Amlodipine Besylate Tablet 10 milligram, and Sulfadoxine and Anti Malarial Kit. As of March 31, 2012, its production capacity under beta lactum included tablets (eight million per day), capsules (one million per day), oral liquid (4600 liters per day), and dry syrup (6000 kilogram per day). Its production capacity under non beta lactum included tablets (one million per day), capsules (one million per day), liquid (1300 liters per day), and dry syrup (50,000 bottles per day). The Company has two manufacturing at Bhiwadi and Haridwar.
          {"success":1,"data":{"address":{"address1":"1506, Chiranjiv Tower,","address2":"43, Nehru Place,,","city":"New Delhi","state":"Delhi","pincode":"110019","telephone1":"011-47589500","telephone2":"","fax1":"011-26213081","fax2":"","email":"cs@medicamen.com","web":"http:\/\/www.medicamen.com"},"management":[{"name":"Rahul Bishnoi","designation":"Chairman"},{"name":"Ashwani Kumar Sharma","designation":"Non Executive Director"},{"name":"Vimal Kumar Shrawat","designation":"Non Executive Director"},{"name":"Sanjay Bansal","designation":"Non Executive Director"},{"name":"Suresh Kumar Singh","designation":"Non Executive Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"Noble Heights, Ist Floor, \nPlot NH 2, C-1 Block LS","address2":"","address3":"","address4":"","telephone":"011-49411000","fax":"011-41410591","email":"delhi@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"New Delhi","state":"Delhi","pincode":"110058"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"531146","nseId":"MEDICAMEQ","series":"EQ","isinid":"INE646B01010"}}}
          • Registered Office

          • Registrars

          • Management

            • Rahul Bishnoi

              Chairman

            • Ashwani Kumar Sharma

              Non Executive Director

            • Vimal Kumar Shrawat

              Non Executive Director

            • Sanjay Bansal

              Non Executive Director

            • Suresh Kumar Singh

              Non Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              531146

            • NSE:

              MEDICAMEQ

            • Series

              EQ

            • ISIN

              INE646B01010

          Advisory Alert:

          It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347